chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; The vaccine was given after it was expired after the expiration date of 03/11/2023 came out the freezer; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vaccine was given after it was expired after the expiration date of 03/11/2023 came out the freezer) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 074B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Mar-2023 at 1:30 PM, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 15-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vaccine was given after it was expired after the expiration date of 03/11/2023 came out the freezer). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The vaccine was given after it was expired after the expiration date of 03/11/2023 came out the freezer) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (The vaccine was given after it was expired after the expiration date of 03/11/2023 came out the freezer).    Concomitant medication was not reported.  The vaccine had remained frozen until removed on 3/15/23 at 08:30 and placed in the refrigerator. The vial had not been exposed to any temperature excursions. Two doses of the expired vaccine were administered 3/15/23 at 13:30.  The vaccine was given to two patients.  Treatment drug was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-715908 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 16-Mar-2023: Live follow-up added: expiration date added. On 16-Mar-2023: Live follow-up added: Narrative updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-715908:1st patient
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Circumstance or information capable of leading to medication error, No adverse event
Clinical narrative: No adverse event; not sure if it was the new Bivalent or the monovalent; This spontaneous case was reported by a consumer and describes the occurrence of CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (not sure if it was the new Bivalent or the monovalent) and NO ADVERSE EVENT (No adverse event) in a 70-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     The information was unknown whether the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. No medical history was not reported.     On 25-Sep-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 25-Sep-2022, the patient experienced CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (not sure if it was the new Bivalent or the monovalent). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (not sure if it was the new Bivalent or the monovalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (not sure if it was the new Bivalent or the monovalent).    The concomitant medication was not reported.  The patient had all four Moderna Covid shots.  The treatment medication was not reported. The reporter would like to know whether there was a 5th shot or need another dose.
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: 1 adult Patient received a bivalent dose Moderna COVID19 vaccine 0.25ml as a first dose; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (1 adult Patient received a bivalent dose Moderna COVID19 vaccine 0.25ml as a first dose) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .25 milliliter. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (1 adult Patient received a bivalent dose Moderna COVID19 vaccine 0.25ml as a first dose) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (1 adult Patient received a bivalent dose Moderna COVID19 vaccine 0.25ml as a first dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (1 adult Patient received a bivalent dose Moderna COVID19 vaccine 0.25ml as a first dose).    No concomitant medications were reported. It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Expired vaccine administered to a 10 month old patient, Dose administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to a 10 month old patient, Dose administered after 30-day Use By Date) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Mar-2023, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2023,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to a 10 month old patient, Dose administered after 30-day Use By Date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to a 10 month old patient, Dose administered after 30-day Use By Date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to a 10 month old patient, Dose administered after 30-day Use By Date).    Concomitant medications details were not reported by the reporter. Patient age was reported as 10 months. Vial was initially stored in the refrigerator on 09-Mar-2023. Vial size was reported as 2 ml. Vial did not undergo any temperature excursions. Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-715994 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-715994:Patient 02
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Therapeutic response unexpected
Clinical narrative: After getting that first shot dose I could breathe through my nose better; No adverse event; This spontaneous case was reported by a patient and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (After getting that first shot dose I could breathe through my nose better) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     Concurrent medical conditions included Breathing difficult.    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (After getting that first shot dose I could breathe through my nose better) and NO ADVERSE EVENT (No adverse event). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (After getting that first shot dose I could breathe through my nose better) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for THERAPEUTIC RESPONSE UNEXPECTED (After getting that first shot dose I could breathe through my nose better).    No concomitant medications were provided. The patient was used to be a shallow breather. After getting that first shot patient could breathe through nose better.  No treatment medication was provided.
Age: 32.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Vial was stored in the fridge since 23JAN2023 and administered on 15MAR2023; No adverse event; 1 dose of Moderna COVID-19 Vaccine Bivalent was administered BUD on 15MAR2023.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (1 dose of Moderna COVID-19 Vaccine Bivalent was administered BUD on 15MAR2023.), PRODUCT STORAGE ERROR (Vial was stored in the fridge since 23JAN2023 and administered on 15MAR2023) and NO ADVERSE EVENT (No adverse event) in a 32-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 041H22A) for COVID-19 prophylaxis.     no known allergy or relevant medical historical conditions, concomitant diseases and risk factor.  Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Dose 1) on 23-Dec-2020 and PFIZER BIONTECH COVID-19 VACCINE (Dose 2) on 08-Jan-2021. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 15-Mar-2023, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 15-Mar-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (1 dose of Moderna COVID-19 Vaccine Bivalent was administered BUD on 15MAR2023.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was stored in the fridge since 23JAN2023 and administered on 15MAR2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (1 dose of Moderna COVID-19 Vaccine Bivalent was administered BUD on 15MAR2023.), PRODUCT STORAGE ERROR (Vial was stored in the fridge since 23JAN2023 and administered on 15MAR2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (1 dose of Moderna COVID-19 Vaccine Bivalent was administered BUD on 15MAR2023.) and PRODUCT STORAGE ERROR (Vial was stored in the fridge since 23JAN2023 and administered on 15MAR2023).    The patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Dosage text of suspect Spikevax Bivalent was reported as Initial booster.  No concomitant medications was reported.  Vial was stored in the fridge since 23-Jan-2023. No AEs were reported.  No treatment medications was reported.
Sex: U
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error, No adverse event
Clinical narrative: Circumstance or information capable of leading to medication error; no adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error) and NO ADVERSE EVENT (no adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error) and NO ADVERSE EVENT (no adverse event). At the time of the report, CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error).    No concomitant medications were reported. No treatment details were reported.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19
Clinical narrative: Patient still got COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Patient still got COVID) in an adult female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Patient still got COVID). At the time of the report, COVID-19 (Patient still got COVID) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Patient previously had 3 Moderna shots. No concomitant medication was reported.    Reporter said he knew a woman who lives next door who was very healthy because she walked a lot and patient has received 4 shots of the Moderna, but she still got COVID. He said "that shit didn't work". No treatment information was reported.   Reporter did not allow further contact
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Adverse drug reaction, Biopsy skin abnormal, Blood creatinine increased, Dermatitis, Dermatitis contact
Clinical narrative: Roughly 10 days after getting the bivalent booster, he developed dermatitis over the inoculation site of the right deltoid.  This spread to involved both arms.  Rash is pruritic.  He did not present for medical care until February of 2022 after being prompted by his dentist.  He continued to have the most significant dermatitis in a 10cm area around the inoculation site, otherwise had a confluent, pruritic, erythematous macular rash with skin edema involving both upper extremities and sparing all other areas.  Rash improved with prednisone but did not fully resolve and started worsening within a week of stopping prednisone.  He had started losartan about a month prior to getting the vaccine and prior to the onset of the rash.  After biopsy results per below, losartan was stopped and he was started on topical triamcinolone with some improvement in symptoms after 2 weeks which is as of the timing of this report.
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dermatitis psoriasiform, Eosinophil count decreased, Full blood count abnormal, Injection site dermatitis, Rash erythematous
Clinical narrative: Roughly 10 days after getting the bivalent booster, he developed dermatitis over the inoculation site of the right deltoid.  This spread to involved both arms.  Rash is pruritic.  He did not present for medical care until February of 2022 after being prompted by his dentist.  He continued to have the most significant dermatitis in a 10cm area around the inoculation site, otherwise had a confluent, pruritic, erythematous macular rash with skin edema involving both upper extremities and sparing all other areas.  Rash improved with prednisone but did not fully resolve and started worsening within a week of stopping prednisone.  He had started losartan about a month prior to getting the vaccine and prior to the onset of the rash.  After biopsy results per below, losartan was stopped and he was started on topical triamcinolone with some improvement in symptoms after 2 weeks which is as of the timing of this report.
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Rash macular, Rash pruritic, Skin oedema
Clinical narrative: Roughly 10 days after getting the bivalent booster, he developed dermatitis over the inoculation site of the right deltoid.  This spread to involved both arms.  Rash is pruritic.  He did not present for medical care until February of 2022 after being prompted by his dentist.  He continued to have the most significant dermatitis in a 10cm area around the inoculation site, otherwise had a confluent, pruritic, erythematous macular rash with skin edema involving both upper extremities and sparing all other areas.  Rash improved with prednisone but did not fully resolve and started worsening within a week of stopping prednisone.  He had started losartan about a month prior to getting the vaccine and prior to the onset of the rash.  After biopsy results per below, losartan was stopped and he was started on topical triamcinolone with some improvement in symptoms after 2 weeks which is as of the timing of this report.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 4/1/21 Lot# Ew0150;  Pfizer 4/22/21 Lot# Ew0170;  Pfizer 2/4/22 Lot# 330368D
Age: 74.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: COVID-19, Cough, Malaise, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: On 02/10/2023, I felt malaise.  Coughing, runny nose, a mild case.  I took Paxlovid the day I was tested, 02/12/2023. After five days, I felt fine.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: After 10 minutes of observation,  patient reported to staff that her hand felt numb with some tingling sensations. No issue with breathing. After a further 5 or 10 minutes the patient said both hands felt numb and started tingling.  We offered to call EMS for patient but she said her brother would pick her up and take her to urgent care.
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Atrial fibrillation, Electrocardiogram ambulatory
Clinical narrative: I experienced AFib in late January 2023. I went to see my PCP on 02/09/2023 and he diagnosed me with AFib and have been wearing a heart monitor since 03/15/2023.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines Moderna 3/23/21 Lot# 008B21A;  Moderna 4/20/1 Lot# 002C21A;  Moderna 12/1/21 Lot# 031H21A;  Pfizer 9/15/22 Lot# GH9702
Age: 80.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: COVID-19, Cough, Nasopharyngitis, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I came home, started throwing out, I called my doctor. I took COVID-19 test and it was Positive. I had a cold and a cough, had fever the first day (101).
Age: 80.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: Vomiting
Clinical narrative: I came home, started throwing out, I called my doctor. I took COVID-19 test and it was Positive. I had a cold and a cough, had fever the first day (101).
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; they accidentally administered 1 dose of Moderna COVID-19 Vaccine to a patient on 16MAR2023 but vial expired on 12MAR2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (they accidentally administered 1 dose of Moderna COVID-19 Vaccine to a patient on 16MAR2023 but vial expired on 12MAR2023) and NO ADVERSE EVENT (No adverse event) in a 13-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 071B22A) for COVID-19 prophylaxis.     no known allergy or relevant medical historical conditions, concomitant diseases and risk factor.   On 16-Mar-2023, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 16-Mar-2023,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (they accidentally administered 1 dose of Moderna COVID-19 Vaccine to a patient on 16MAR2023 but vial expired on 12MAR2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (they accidentally administered 1 dose of Moderna COVID-19 Vaccine to a patient on 16MAR2023 but vial expired on 12MAR2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (they accidentally administered 1 dose of Moderna COVID-19 Vaccine to a patient on 16MAR2023 but vial expired on 12MAR2023).    The patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  No concomitant medications were reported.  No adverse events were reported.  No treatment medications were reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hypersomnia, Pain, Pyrexia, Sinus congestion
Clinical narrative: I had chills and a fever and sinus congestion, and my body hurt and slept for 24 hours.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event; Patient received first booster dose as Moderna COVID-19 Monovalent on 24-Feb-2023; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received first booster dose as Moderna COVID-19 Monovalent on 24-Feb-2023) and NO ADVERSE EVENT (No adverse event) in a 7-decade-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018C22A) for COVID-19 prophylaxis.   No Medical History information was reported.   On 24-Feb-2023, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2023, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced WRONG PRODUCT ADMINISTERED (Patient received first booster dose as Moderna COVID-19 Monovalent on 24-Feb-2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient received first booster dose as Moderna COVID-19 Monovalent on 24-Feb-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient received first booster dose as Moderna COVID-19 Monovalent on 24-Feb-2023).    No concomitant medications were reported.  No treatment information was provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No adverse event; Second dose administered on 16-Mar-2023 and first dose on 13-Mar-2021; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose administered on 16-Mar-2023 and first dose on 13-Mar-2021) and NO ADVERSE EVENT (No adverse event) in a 61-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 071B22A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 16-Mar-2023, received second dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2023,  after starting mRNA-1273 (Spikevax), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose administered on 16-Mar-2023 and first dose on 13-Mar-2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose administered on 16-Mar-2023 and first dose on 13-Mar-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose administered on 16-Mar-2023 and first dose on 13-Mar-2021).    No concomitant medications was reported. It was reported that no adverse events was reported by the patient. No treatment drug details was reported.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Expired Moderna Covid-19 Vaccine, "We gave it to 2 of our patients yesterday; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 Vaccine, "We gave it to 2 of our patients yesterday) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 071B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 16-Mar-2023, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 16-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 Vaccine, "We gave it to 2 of our patients yesterday). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 Vaccine, "We gave it to 2 of our patients yesterday) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 Vaccine, "We gave it to 2 of our patients yesterday).    No concomitant medications were reported.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-715997 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-715997:same reporter, Patient 2
Age: 68.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Blood test, Mixed connective tissue disease
Clinical narrative: I had my vaccination on 09/16/2022. I am unsure of exact dates but I was diagnosed with Mixed Connective Tissue Disorder. I was diagnosed earlier in 07/2022 but the main diagnoses were in 11/2022 with a Rheumatologist. I am being with specialty care from 04/2023 for additional blood tests.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Fatigue, Headache, Paranasal sinus discomfort
Clinical narrative: It started when I woke up with a tight throat. I started feeling some sinus pressure as well but also got on a plane that day so I felt it stronger. I took a home COVID test and it was negative. The next day from travelling, I had additional cold symptoms that dealt with sinus congestion. I think I also had a bit of a cough and a headache. On the 11th and the 12th of March I took another test and that one was positive. I developed on these days a mild fever and fatigue. I called the doctor on the 13th and was given Paxlovid and I took the 5 day course. Symptoms continued to be mild cold like symptoms through the week and was able to continue my normal daily life. On the 17th I took a test and was negative and have been negative since.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia, SARS-CoV-2 test positive, Sinus congestion, Throat tightness
Clinical narrative: It started when I woke up with a tight throat. I started feeling some sinus pressure as well but also got on a plane that day so I felt it stronger. I took a home COVID test and it was negative. The next day from travelling, I had additional cold symptoms that dealt with sinus congestion. I think I also had a bit of a cough and a headache. On the 11th and the 12th of March I took another test and that one was positive. I developed on these days a mild fever and fatigue. I called the doctor on the 13th and was given Paxlovid and I took the 5 day course. Symptoms continued to be mild cold like symptoms through the week and was able to continue my normal daily life. On the 17th I took a test and was negative and have been negative since.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: none at this time
Age: 4.0
Sex: M
Vaccine: DTAP, VARCEL
Symptoms: Product administration error
Clinical narrative: Poked child with an unfilled syringe. Bandd aid applied. Reviewed to watch for s/s of redness at site. Immunization supervisor notified. All questions answered.
Age: 97.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 RNA, SARS-CoV-2 test positive
Clinical narrative: HOSPITALIZATION AND DEATH RELATED TO COVID-19 FOLLOWING COMPLETION OF PRIMARY COVID VACCINE SERIES
Age: 78.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Decreased appetite, Diarrhoea, Headache
Clinical narrative: I began to throw up and have diarrhea. On 2/24/2023, I took a home antigen test and got a positive result. I called a telemedicine number, and I was prescribed PAXLOVID and an anti-nausea medicine. I also took OTC guaifenesin. The anti-nausea medicine worked right away. At the time of this writing, I have general malaise, cough, headaches, and altered sense of taste. I've lost my appetite, so I have also lost 8 lbs. I now weigh 104 or 105 lbs. My doctor suggested that I possibly had long COVID-19. I was due to undergo eye surgery on 3/15/2023. I was not able to undergo the surgery, because I took a COVID-19 test and got a positive result.
Age: 78.0
Sex: F
Vaccine: COVID19-2
Symptoms: Malaise, Nausea, SARS-CoV-2 test positive, Taste disorder, Vomiting
Clinical narrative: I began to throw up and have diarrhea. On 2/24/2023, I took a home antigen test and got a positive result. I called a telemedicine number, and I was prescribed PAXLOVID and an anti-nausea medicine. I also took OTC guaifenesin. The anti-nausea medicine worked right away. At the time of this writing, I have general malaise, cough, headaches, and altered sense of taste. I've lost my appetite, so I have also lost 8 lbs. I now weigh 104 or 105 lbs. My doctor suggested that I possibly had long COVID-19. I was due to undergo eye surgery on 3/15/2023. I was not able to undergo the surgery, because I took a COVID-19 test and got a positive result.
Age: 78.0
Sex: F
Vaccine: COVID19-2
Symptoms: Weight decreased
Clinical narrative: I began to throw up and have diarrhea. On 2/24/2023, I took a home antigen test and got a positive result. I called a telemedicine number, and I was prescribed PAXLOVID and an anti-nausea medicine. I also took OTC guaifenesin. The anti-nausea medicine worked right away. At the time of this writing, I have general malaise, cough, headaches, and altered sense of taste. I've lost my appetite, so I have also lost 8 lbs. I now weigh 104 or 105 lbs. My doctor suggested that I possibly had long COVID-19. I was due to undergo eye surgery on 3/15/2023. I was not able to undergo the surgery, because I took a COVID-19 test and got a positive result.
Age: 42.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Malaise, Menstruation irregular, Pain, Pyrexia
Clinical narrative: The vaccine made me sick with chills, fever and body aches for three days. In 10/2022, I began having very irregular menstrual cycles. I am unable to take hormones as I have bad side effects. I will start my period between 7 to 8 days early and my cycle will last nine days. At this time, I am waiting or my system to self-regulate.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: none
Age: 59.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Chills, Cough, Diarrhoea, Fatigue
Clinical narrative: That evening I was exhausted, fever peaking at 103, chills, body aches, congestion and developed a cough later that evening.  Went to doctor., Gave me an IV with fever and pain meds.  Fever, chills and body aches lasted 3 days.  Bad diarrhea 1 day.  Symptoms subsided on days 4 and 5 with no fever, and body aches gone.  fatigue and cough lingered.
Age: 59.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: That evening I was exhausted, fever peaking at 103, chills, body aches, congestion and developed a cough later that evening.  Went to doctor., Gave me an IV with fever and pain meds.  Fever, chills and body aches lasted 3 days.  Bad diarrhea 1 day.  Symptoms subsided on days 4 and 5 with no fever, and body aches gone.  fatigue and cough lingered.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, COVID-19, Cardio-respiratory arrest, Death, Endotracheal intubation
Clinical narrative: 3RD COVID VACCINE GIVEN 9/21/21, PFIZER, LOT # UNAVAILABLE; pt to ED with abdominal pain and requesting staples to be removed; found to be positive for COVID; DKN and renal failure; pt coded and ROSC was achieved; intubated; ICU; pt's condition worsened; DNR, comfort care; palliatively extubated; pt passed away in the hospital
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: General physical health deterioration, Intensive care, Renal failure, Renal transplant, SARS-CoV-2 test positive
Clinical narrative: 3RD COVID VACCINE GIVEN 9/21/21, PFIZER, LOT # UNAVAILABLE; pt to ED with abdominal pain and requesting staples to be removed; found to be positive for COVID; DKN and renal failure; pt coded and ROSC was achieved; intubated; ICU; pt's condition worsened; DNR, comfort care; palliatively extubated; pt passed away in the hospital
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 RNA, SARS-CoV-2 test positive
Clinical narrative: HOSPITALIZATION RELATED TO COVID-19 FOLLOWING COMPLETION OF PRIMARY COVID VACCINE SERIES
Age: 23.0
Sex: M
Vaccine: COVID19-2, TDAP
Symptoms: Expired product administered
Clinical narrative: Pfizer Bivalent (adult 12y+ gray cap) was administered after the beyond use date.  Manufacturer was contacted, with no further vaccine stability information.  Patient was contacted regarding incident and opted to not revaccinate at this time.  Patient will discuss with provider at upcoming appointment.  No adverse symptoms noted.
Age: 51.0
Sex: M
Vaccine: HIBV
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Adult patient was given a HIB vaccine instead of a shingrix vaccine
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Burning sensation, Rash, Rash pruritic
Clinical narrative: Developed itchy, burning, painful rash on right side of neck
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Provider ordered Pfizer bivalent booster.  Pfizer monovalent booster was administered.  Lot FR2583, exp 07/2023.
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient was given second dose of covid vaccine 7 days too early. Patient received first dose on 02/27/2023 and second dose was given on 03/20/2023 when it should have been given on 03/27/2023 at the earliest.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Pain, Ultrasound uterus abnormal, Uterine mass
Clinical narrative: Starting in July of 2022 I started having excessive menstrual bleeding that could not be controlled by medication. As of March 13, 2023, they located a baseball size in my uterus. I was also having pain that would not stop. The doctor tried 3 birth control medication which did not help. I have a follow up MRI on April 10, 2023. I am also scheduled to have a hysterectomy on April 28, 2023. My Ob-Gyn discovered the mass. I am still having the issue and awaiting surgery. I had dose 6 of the Pfizer Bivalent vaccine on November 4, 2022. This did not change the issue.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Blood test, Deep vein thrombosis, Pulmonary embolism, Thrombectomy
Clinical narrative: I had deep vein thrombosis and a pulmonary embolism. I went to the emergency room and was admitted to the hospital for a thrombectomy. I stayed in the hospital for two days and now I'm anticoagulation therapy and blood thinners.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan
Clinical narrative: I had deep vein thrombosis and a pulmonary embolism. I went to the emergency room and was admitted to the hospital for a thrombectomy. I stayed in the hospital for two days and now I'm anticoagulation therapy and blood thinners.
Age: 16.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Rash
Clinical narrative: Benadryl Diphenhydramine HCL Time: 10:15 am Dosage: 10ml - rash/redness on face  Dexamethasone Time: 10:15 am Dosage: 8mg Tab- rash/redness on face Diphenhydramine HCL injection 10:37 am Dosage: 50mg/ml given intramuscular injection RT arm- rash/redness on face Manual BP 10:48 118/78 -Itchiness on face Pt discharge 11:08 Dr.
Age: 31.0
Sex: F
Vaccine: COVID19-2
Symptoms: Canalith repositioning procedure, Electrocardiogram abnormal, Orthostatic hypotension, Vertigo
Clinical narrative: On 12/07/2022 in the middle of me working out my heart rate went up to the 200s. I went to the doctor and they did a EKG and I was diagnosed with Orthostatic Hypotension. In February I was also diagnosed with vertigo. I am scheduled to go to a neurologist now.
Age: 63.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: COVID-19, Headache, Malaise, Oropharyngeal pain, Pyrexia
Clinical narrative: The family and I had gone out for lunch, I was sneezing a bit but didn't think anything of it. I woke up on December 23, 22 not feeling a really well and had a slight fever. I took a home COVID-19 test that came back positive immediately. I moved upstairs to quarantine, I developed a headache, my fever was getting worse. We called the doctor and had a telehealth visit, I was prescribed PAXLOVID. I wasn't sure about taking it until the next day. That day I woke up with a really sore throat, so I started the PAXLOVID. Within twelve hours of taking the pills I felt like I wasn't getting worse, but it did take three or four days before I started feeling better. It took three weeks before I felt like myself.
Age: 63.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: SARS-CoV-2 test positive, Sneezing
Clinical narrative: The family and I had gone out for lunch, I was sneezing a bit but didn't think anything of it. I woke up on December 23, 22 not feeling a really well and had a slight fever. I took a home COVID-19 test that came back positive immediately. I moved upstairs to quarantine, I developed a headache, my fever was getting worse. We called the doctor and had a telehealth visit, I was prescribed PAXLOVID. I wasn't sure about taking it until the next day. That day I woke up with a really sore throat, so I started the PAXLOVID. Within twelve hours of taking the pills I felt like I wasn't getting worse, but it did take three or four days before I started feeling better. It took three weeks before I felt like myself.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Product preparation error, Single component of a two-component product administered
Clinical narrative: diluent injected prior to mixing with powder
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Loss of consciousness, Syncope
Clinical narrative: Patient received her first Janssen covid vaccine. Ten  minutes after receiving the vaccine, she fainted and fell out of her chair. At that time, the pharmacist, went to check on her and call the paramedics. Patient regained consciousness within 60 seconds. The paramedics arrived and provided her with care. After an hour, the patient said she felt better. She declined the paramedics offer to transport to the hospital. She left the building with her mother.
Age: 68.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: COVID-19, Decreased appetite, Fatigue, Headache, Nasopharyngitis
Clinical narrative: I had vaccination on 09/17/2022. I started to experience a headache congestion and feeling like coming down with a cold on 11/04/2022. I tested COVID-19 negative on 11/04/2022. On 11/06/2022 my head was pounding with nausea, vomiting, exhaustion. I tested COVID-19 positive on 11/06/2022. I had not been able to eat till 12/2023 and lost weight down to 100lbs. I have not recovered as of 03/20/2023. I have not made any follow up appointments.
Age: 68.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: Nausea, Respiratory tract congestion, SARS-CoV-2 test positive, Vomiting, Weight decreased
Clinical narrative: I had vaccination on 09/17/2022. I started to experience a headache congestion and feeling like coming down with a cold on 11/04/2022. I tested COVID-19 negative on 11/04/2022. On 11/06/2022 my head was pounding with nausea, vomiting, exhaustion. I tested COVID-19 positive on 11/06/2022. I had not been able to eat till 12/2023 and lost weight down to 100lbs. I have not recovered as of 03/20/2023. I have not made any follow up appointments.
Age: 9.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect route of product administration
Clinical narrative: vaccine syringe was mistaken for PPD syringe and given subcutaneously in right forearm
Age: 74.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: COVID-19, Cough, Nasal congestion, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: I had a sore throat, dry cough that lasted for a couple weeks, and a stuffy nose. I tested positive for COVID-19 at home. I called my PCP and she said just to drink plenty of fluids. I tested negative on 12/23/2022.
Age: 52.0
Sex: M
Vaccine: COVID19-2
Symptoms: Computerised tomogram thorax abnormal, Dyspnoea, Flatulence, Pneumonia, X-ray normal
Clinical narrative: The night before I felt like I had gas in my chest. I drove myself to the emergency room early the next morning because I could not breath. They did an x-ray that did not show anything, they also did CT scan that showed I had Multifocal pneumonia. I was given the first dose of amoxicillin at the hospital and sent home a prescription. On Friday I went to see my primary care physician who discontinued that medication and switched me to a broad-spectrum antibiotic.
Age: 41.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Axillary pain, Lymphadenopathy, Mammogram abnormal, Peripheral swelling, Tenderness
Clinical narrative: Four hours after vaccine started feeling under arm pain, swelling and tenderness in the same arm  as the vaccination. Lasted about 2 days then subsided. Then  about 4 months started experiencing under arm pain again and tenderness again. Went to doctor and was advised to get an Ultrasound. My doctor wanted me to have my yearly Mammogram, so it was decided that I would have the area observed at the same appointment. Was told that Lymph nodes were slightly swollen and to come back in 3 months for further testing. Pain has subsided since then.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: On Wednesday 02/22/2023, at approximately 10:30 AM, an unsheltered 57-year-old male patient was approached and offered COVID-19 vaccination by team. After searching patient?s vaccination record on Registry system, EMT and RN, PHN noted two patient accounts with the same name and date of birth.  The first patient profile was unviewable and despite a work-around, profile still stated "Sharing Date must fall between birth date and today's date". The second profile did not display any COVID-19 vaccinations. EMT and RN, PHN searched for patient?s name and DOB on system, which also displayed no previous vaccinations. EMT and RN, PHN asked patient several times if he received any COVID-19 vaccines in the past and patient denied receiving any previous COVID-19 vaccines.  RN, PHN and EMT asked which COVID-19 vaccine patient wanted to receive and provided vaccine education and information for Pfizer and Moderna COVID-19 vaccines. Patient requested to receive Moderna COVID-19 vaccine as a primary dose.  Patient was educated by, RN, PHN on risks, benefits, common side effects, and when to seek emergency care.  Patient verbalized understanding and consented to receiving Moderna COVID-19 vaccine.  At 11:02 AM, patient received Moderna monovalent COVID-19 vaccine (Lot #: 074B22A) as a primary first dose on (right deltoid), administered by RN, PHN.  Patient denied experiencing any adverse symptoms during post-vaccination observation period.  When RN, PHN began to document this patient?s Moderna monovalent dose into the system, a Pfizer monovalent COVID-19 dose displayed (Lot: FK9896) on 01/26/2022.  At 11:04 AM, RN, PHN completed a medical consultation with on-call physician Dr. regarding previous Pfizer COVID-19 vaccination. Dr. suggested that the patient receive a COVID-19 bivalent booster two months from now.  RN, PHN informed patient of COVID-19 bivalent booster recommendation and observed patient leave area with steady balance and gait.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Dyspnoea, Feeling abnormal, Hypersomnia
Clinical narrative: I was positive for COVID-19 on 01JAN2023, I couldn't breathe I had a horrible cough and couldn't think straight. I slept a lot, I didn't have a fever and tired. I contacted my doctor and her prescribed me PAXLOVID. I started feeling better 5 days after but then I started feeling bad and it was recurring for 2 weeks.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Mental impairment, SARS-CoV-2 test positive
Clinical narrative: I was positive for COVID-19 on 01JAN2023, I couldn't breathe I had a horrible cough and couldn't think straight. I slept a lot, I didn't have a fever and tired. I contacted my doctor and her prescribed me PAXLOVID. I started feeling better 5 days after but then I started feeling bad and it was recurring for 2 weeks.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Fatigue, Respiratory tract congestion, SARS-CoV-2 test
Clinical narrative: January sympotoms congestion, fatigu and coughing lasted for 2 weeks towards end of January symptoms returned 02/20/2023 went to see doctor, received checked vitals all normal.  03/10/2023 symptoms subsided.